Filter By Industry
Filter By Tag

Newsroom

Oncoheroes Biosciences Inc Press releases

1 - 1 of 1 Press Release

Sep 17, 2019
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered..


Oncoheroes Biosciences Inc RSS Feed